Last week, Pfizer voluntarily recalled three of their hypertension drugs, including Accuretic, due to nitrosamine levels in the medication. Nitrosamine is common and safe in low amounts, but the drug pushed people above the acceptable daily intake limit, which increased the risk of cancer down the road.
In a recent article in Yahoo Finance, ‘As President Biden eyes drug pricing, expert laments ‘failure of democracy’. The article states that 25% of Americans can’t afford their prescriptions and one-third have skipped a prescription due to cost.
Pharmacists have been a godsend to many people looking for healthcare during COVID as they stepped up during the pandemic to offer COVID testing and vaccinations, a departure from traditional healthcare delivery. It’s paid off. As of Jan. 12, retail pharmacies participating in the Federal Retail Pharmacy Program have administered more than 215.9 million doses.
Co-founders Siva Mohan and Tom Dorsett come from very different backgrounds; one is a talented cardiologist and the other a successful entrepreneur. What they share is an “abiding optimism”, complete faith that there are no unsolvable problems.
A Conversation with RazorMetrics Co-Founder, Cardiologist, and Entrepreneur Siva Mohan, MD, FACC, FSCAI
The Partnership Collective is comprised of tightly integrated health technology companies with a common goal: drug cost containment and reduction.
Partners in the Collective are benefit management platforms and other types of application providers that count large employers and health plans as clients. RazorMetrics has launched the new initiative to integrate its solution into partners’ technology to seamlessly add drug-cost savings to their existing offerings. Access to the collective will help benefit providers attract new clients and retain current ones by offering a more competitive benefit.
Sopris Capital, a leading healthcare investment firm, is entering the drug cost transparency space with a new partnership with RazorMetrics, a rapidly growing healthcare technology company focused on lowering pharmacy costs for at-risk employers and health plans. The Series A investment of $6,000,000 was led by Sopris and other individual investors including long-term entrepreneurs Joel Trammell and Jonathan Weiner.
Tom: What important role do pharmacists play in Medi-Cal (California Medicaid) Managed Care? Johanna: In the managed care arena, there are experts in economics,
I am an optimist. I gravitate toward stories that are heartwarming and inspirational. If you’re like me, then you likely experienced COVID news as an
Continuing our blog series, “The Unsung Heroes of COVID, Interviews with HR Professionals” Tom Dorsett, CEO of RazorMetrics, spoke with Debbie Smith, Executive Vice President,
And, we are waiting…
Contact us, and we will be more than happy to answer all of your questions.
